SCHEMBL6132960

SCHEMBL6132960

CC1(C)COCCN1Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.44
JAK1 P23458 1/20 0.44
SIGMAR1 Q99720 4/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
CYP3A4 P08684 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PDE1B Q01064 1/20 0.40
MC4R P32245 1/20 0.40
GRM2 Q14416 1/20 0.39
POLB P06746 2/20 0.39
GAA P10253 1/20 0.39
ELANE P08246 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.38
OPRL1 P41146 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11018891 0.84 SIGMAR1 (0.47) SIGMAR1ALDH1A1POLBLMNATSHR
SCHEMBL5692162 0.83 GAA (0.41) SIGMAR1ALDH1A1CYP3A4HSD17B10MC4R
SCHEMBL6133227 0.81 ALDH1A1 (0.39) SIGMAR1KDM4EALDH1A1HPGDHTT
SCHEMBL15573689 0.80 FKBP1A (0.41) JAK2JAK1SIGMAR1ALDH1A1HTT
SCHEMBL6132839 0.80 SIGMAR1 (0.41) SIGMAR1KDM4EALDH1A1HPGDHTT
SCHEMBL6133048 0.79 MEN1 (0.39) SIGMAR1KDM4EALDH1A1HPGDHTT
SCHEMBL2599474 0.78 CYP2A13 (0.39) SIGMAR1ALDH1A1CYP3A4POLBLMNA
SCHEMBL27083845 0.78 LIPG (0.47) JAK2JAK1PDE1BGRM2
SCHEMBL2770419 0.78 MCHR1 (0.42) SIGMAR1KDM4EALDH1A1HPGDHTT
SCHEMBL21028137 0.76 RORC (0.41) JAK2JAK1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 JAK2 158/4885JAK1 691/4885SIGMAR1 1572/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 JAK2 262/4885JAK1 592/4885SIGMAR1 670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.